Axsome Therapeutics, Inc. (NASDAQ:AXSM) Director Mark E. Saad Sells 11,016 Shares
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Mark E. Saad sold 11,016 shares of the company’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $91.31, for a total transaction of $1,005,870.96. Following the completion of the sale, the director now owns 10,002 shares in […]
More Stories
Kaixin Holdings (NASDAQ:KXIN) Short Interest Update
Kaixin Holdings (NASDAQ:KXIN – Get Free Report) was the target of a large increase in short interest during the month...
Liberty Broadband Co. (NASDAQ:LBRDP) Short Interest Up 292.7% in December
Liberty Broadband Co. (NASDAQ:LBRDP – Get Free Report) was the target of a large increase in short interest during the...
Short Interest in Global X Solar ETF (NASDAQ:RAYS) Declines By 76.8%
Global X Solar ETF (NASDAQ:RAYS – Get Free Report) was the recipient of a large drop in short interest in...
Invesco S&P SmallCap Industrials ETF (NASDAQ:PSCI) Short Interest Down 91.2% in December
Invesco S&P SmallCap Industrials ETF (NASDAQ:PSCI – Get Free Report) was the target of a significant decline in short interest...
Pulmatrix, Inc. (NASDAQ:PULM) Sees Large Decrease in Short Interest
Pulmatrix, Inc. (NASDAQ:PULM – Get Free Report) was the recipient of a significant decline in short interest in December. As...
Magna Terra Minerals (CVE:MTT) Shares Up 50% – Here’s Why
Magna Terra Minerals Inc. (CVE:MTT – Get Free Report)’s share price traded up 50% on Tuesday . The company traded...